Axon Enterprise, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, disclosing third-quarter net sales of $908.6 million and total assets of approximately $8.83 billion as of quarter-end.

Key Highlights

  • Quarterly net sales: $908,554 thousand for the three months ended September 30, 2026, up from $710,641 thousand in the same period of 2025, according to the filing.
  • Nine-month net sales: $2,620,288 thousand for the nine months ended September 30, 2026, compared with $1,982,812 thousand for the nine months ended September 30, 2025.
  • Total assets: $8,832,777 thousand as of September 30, 2026, versus $7,000,313 thousand as of December 31, 2025.
  • Retained earnings: $1,192,415 thousand as of September 30, 2026, up from $936,670 thousand at December 31, 2025.
  • Long-term notes payable: $2,868,037 thousand as of September 30, 2026, compared with $1,730,170 thousand at December 31, 2025.
  • Shares outstanding: 81,411,739 shares of common stock outstanding as of September 30, 2026, with 81,432,712 shares outstanding as of October 30, 2026, per the filing.
  • Strategic investments: $924,934 thousand as of September 30, 2026, rising from $416,833 thousand at December 31, 2025.

Axon Enterprise Third-Quarter 2026 Financial Results and Balance Sheet Position

Axon Enterprise, Inc. (NASDAQ:AXON), headquartered in Scottsdale, Arizona, reported third-quarter 2026 net sales of $908,554 thousand, comprising $471,524 thousand from products and $437,030 thousand from services, according to the filing. For the same quarter of 2025, the company reported net sales of $710,641 thousand, split between $405,399 thousand from products and $305,242 thousand from services. For the nine months ended September 30, 2026, net sales totaled $2,620,288 thousand, versus $1,982,812 thousand for the nine months ended September 30, 2025.

On the cost side, the filing reported cost of product sales of $268,629 thousand and cost of service sales of $124,947 thousand for the three months ended September 30, 2026, bringing total cost of sales to $393,576 thousand for the quarter. Total assets grew to $8,832,777 thousand at September 30, 2026, from $7,000,313 thousand at December 31, 2025. The increase was accompanied by a rise in goodwill to $1,885,348 thousand from $1,370,189 thousand, and in strategic investments to $924,934 thousand from $416,833 thousand, as disclosed in the consolidated balance sheet.

Total stockholders' equity was reported at $3,762,928 thousand as of September 30, 2026, compared with $3,242,658 thousand at December 31, 2025. Long-term notes payable increased to $2,868,037 thousand from $1,730,170 thousand over the same period. Cash and cash equivalents stood at $1,458,817 thousand at quarter-end, up from $1,201,147 thousand at December 31, 2025. The filing notes that forward-looking statements contained therein are subject to the company's cautionary language and the risk factors described in the report and in the 2025 Annual Report on Form 10-K.

What Was Disclosed

Axon Enterprise filed its Form 10-Q for the quarter ended September 30, 2026, reporting quarterly net sales of $908,554 thousand, total assets of $8,832,777 thousand, and stockholders' equity of $3,762,928 thousand, with 81,432,712 shares outstanding as of October 30, 2026.